نتایج جستجو برای: ژن he4

تعداد نتایج: 16408  

Journal: :iranian red crescent medical journal 0
farah farzaneh department of gynecology-oncology, shahid beheshti university of medical sciences, tehran, ir iran zahra honarvar department of gynecology-oncology, shahid beheshti university of medical sciences, tehran, ir iran; preventative gynecology research center, 2nd floor, imam hossein hospital, shahid beheshti university of medical sciences, p. o. box: 1617763141, tehran, ir iran. tel: +98-9133417647 mansoore yaraghi department of gynecology-oncology, shahid beheshti university of medical sciences, tehran, ir iran mehdi yaseri department of statistics and epidemiology, tehran university of medical sciences, tehran, ir iran maliheh arab department of gynecology-oncology, shahid beheshti university of medical sciences, tehran, ir iran maryamsadat hosseini department of gynecology-oncology, shahid beheshti university of medical sciences, tehran, ir iran

results: the only significant difference was the older age of the malignant group vs. benign group (p = 0.001) regarding demographic findings. as concerns the clinical symptoms, presence of abdominal discomfort in pre-diagnosis period was the only significant parameter in malignant group (p = 0.001). additionally, data analysis of patients as a total group showed that specificity (96.4%), posit...

Journal: :The Tohoku journal of experimental medicine 1966
I Yamane T Tsuda

After 10 months of continuous cultivation in vitro, two cell lines (HE3-2 and HE4-2 cell lines) of embryonic tissue origin from Syrian hamsters did not produce tumors upon subcutaneous implantation into the hosts. After 13 months, however, the similar implantation resulted in the development of rapidly growing transplantable fibrosarcomas. The tumor-producing capacity of HE3-2 cell line was hig...

2014

The best available marker for epithelial ovarian cancer is still considered to be CA-125 due to a combination of reliability and general availability. HE4 is more sensitive than specific than CA-125, however the former is not in routine use. NICE still therefore recommends CA-125 rather than HE4. CA-125 is used for the diagnosis of epithelial ovarian cancer. αFP and βHCG are useful for identify...

Journal: :Acta Obstetricia et Gynecologica Scandinavica 2021

Introduction Many women with benign pelvic masses, suspected of ovarian cancer, are unnecessarily referred for treatment at specialized centers. There is an unmet clinical need to improve diagnostic assessment in these patients. Our objective was obtain summary estimates the accuracy human epididymis protein (HE4) diagnosing cancer and compare performance HE4 that antigen 125 (CA125). Material ...

2018
Xiaoling Fu Yangyang Liu Ruiyun Qiu Mohamed F. Foda Yong Zhang Tao Wang Jinshan Li

The magnetic particles have a significant influence on the immunoassay detection and cancer therapy. Herein, the chemiluminescence immunoassay combined with the magnetic particles (MPCLIA) was presented for the clinical determination and analysis of human epididymis protein 4 (HE4) in the human serum. Under the optimized experiment conditions, the secure MPCLIA method can detect HE4 in the broa...

2014
Yaping Tian Chuanxin Wang Liming Cheng Peng Zhang Lin Guo Wanli Liu Zhongying Zhang Yanchun Huang Qishui Ou Xinyu Wen Yuelei Xing Guixi Zheng Ziyong Sun Huijun Li Aimin Zhang Ying Chen Wen Liu Huiming Ye Yi Xu Yishan Huo Jing Chen

OBJECTIVE: The objective of this study was to explore the combined usage of human epididymis protein 4 (HE4) and CA 125 to help the diagnosis and differentiating malignant pelvic masses from benign diseases. METHOD: This was a multicenter clinical study and nine hospitals had been involved and totally 779 patients with pelvic mass have been enrolled. The pathologic diagnosis confirmed that 288 ...

2016
Jae Jun Shin Ye Ji Lee Ranah Kim Da Yong Lee Kyu-Hee Won Byung Chul Jee

OBJECTIVE To estimate the incidence of falsely elevated risk of ovarian malignancy algorithm (ROMA) in a group of women with pathologically confirmed endometrioma and to investigate the associated factors. METHODS One hundred premenopausal women surgically diagnosed with ovarian endometrioma were selected. Preoperative clinical, laboratory, and surgical characteristics were compared between t...

Journal: :Ginekologia polska 2016
Nabil Abdalla Monika Pazura Anna Słomka Robert Piórkowski Włodzimierz Sawicki Krzysztof Cendrowski

OBJECTIVES The aim of the study was to assess the role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies. MATERIAL AND METHODS A retrospective study of 87 patients with endometrial pathologies was conducted. Tumor markers were assessed two weeks before surgical intervention in each subject. The final diagnosis was established on the basis of the h...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Nathalie Scholler Meghan Crawford Alicia Sato Charles W Drescher Kathy C O'Briant Nancy Kiviat Garnet L Anderson Nicole Urban

PURPOSE Efforts to validate ovarian cancer early detection biomarkers with immunoassays are challenged by the limited specimen volumes available. We sought to develop a specimen-efficient assay to measure CA125 in serum, assess its reproducibility, validity, and performance, and test its potential for multiplexing and combining with human epididymis protein 4 (HE4), a promising novel ovarian ca...

2013
Ioannis Hatzipetros Peter Gocze Tamas Koszegi Akos Jaray Laszlo Szereday Beata Polgar Nelli Farkas Balint Farkas

OBJECTIVE Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study was to investigate the clinical potential of 14-3-3 zeta protein for monitoring EOC progression compared with CA-125 and HE4. DESIGN Prospective follow-up study. SETTING University of Pecs Medical Center Department of Obstetrics and Gynecology/Onco...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید